23
Dec

Two months after its self-imposed deadline, the FDA finally signed off on Novo Nordisk’s first weight-loss therapy, a milestone for the company as it blueprints a future in obesity.

…read more

Source: Novo Nordisk kick-starts its diabetes franchise with a long-awaited FDA nod

    

0 No comments